Introduction {#s1}
============

Hemoglobinopathy is a genetic disorder that causes an abnormal structure in the globin chain of the hemoglobin molecule^[@r1]^. Thalassemia occurred when the globin chain(s) of hemoglobin which is defined as α, β, γ, or δ, has been formed at low levels or has not been formed at all^[@r1],[@r2]^. Mutations in the beta-globin chain are quite common^[@r3]^. Hemoglobinopathies can be both heterozygous and homozygous^[@r3]^. The most common hemoglobinopathy in Turkish population is Hemoglobin S (HbS, β6 Glu-Val) which is followed by Hemoglobin D (β121 Glu→Gln)^[@r4],[@r5]^. Hemoglobin Pusan (Hb Pusan) is a heterozygote and a rare hemoglobin variant type which was previously revealed in Korean society, that is identified by the substitution of histidine which is found in the 146^th^ amino acid residue of the beta globulin chain for asparagine amino acid (CAC\>GAC or His\>Asn)^[@r2]^.

Case Report {#s2}
===========

A 25-year-old male patient of Turkish origin was admitted to the University Hospital for thalassemia screening. Physical examination findings of the patient revealed no signs of anemia or other diseases. Liver function tests (aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin and direct bilirubin levels), iron, total iron-binding, B12, and folic acid levels were normal. Serology tests were negative. He was not a smoker. In the hematology panel, hemoglobin (Hb) was 17 g/dL (reference range, 13.2-16.6), red blood cell (RBC) count was 5.95 x10^[@r12]^/ L (reference range, 3.8-5.1), white blood cell (WBC) count was 6.21 x10^[@r12]^/L (reference range, 4.5-10.5), mean corpuscular volume (MCV) was 84.5 fL(reference range, 80-102), and mean corpuscular hemoglobin (MCH) was 28.6 pg (reference range, 25.6-34). Hb value and RBC count are above the normal (17 g/dL and 5.95x10^[@r12]^/L) therefore, there is some degree of erythrocytosis in this case and measured P50 value by using oxymeter was low (20 mmHg) than normal control (26.5 mmHg, reference range 26±1.3 mmHg). In thalassemia analysis examined with high-performance liquid chromatography (HPLC) method, an abnormal unidentified hemoglobin peak (RRT: 1.67 min., %46.9) was detected apart from the identified two basic hemoglobin peaks, which are HbA0 (RRT: 1.00 min., 42.6%) and HbA2 (RRT: 0.88 min., 2.4%), which were defined according to relative retention time (RRT) per minute. When the same sample was examined with Cation exchange HPLC method in a different system, another suspected abnormal hemoglobin peak (RT: 1.68 min., 48.3%), was detected apart from two basic hemoglobin peaks, which are HbA0 (RT: 2.57 min., 39.0%) and HbA2 (RT: 3.73 min., 2.4%) This unknown hemoglobin variant was sent to genetic analysis (DNA chain analysis) for verification. In the DNA sample obtained from the patient's peripheral blood, HBB gene (GRChg37: NM_000518) sequence analysis (5'UTR (-110), exon 1-3, IVS1-2, 3'UTR)) was performed and heterozygous Hb Pusan variant was detected as HBB: c.439C\> A (p. His147Asn). Written informed consent was obtained from the patient for the publication of the case report and the accompanying images.

Discussion {#s3}
==========

This present study examined the clinical features and laboratory findings of a heterozygous hemoglobin variant, which which was defined in the beta globulin chain and which is rare in the Turkish population. Hemoglobin variant detected during routine laboratory evulation was determined as heterozygous Hb Pusan according to genetic analysis results. Physical examination and laboratory results of the case have revealed no findings of anemia. There are no publications or case reports in the literature indicating that this variant type, which was previously revealed in a Korean society, was detected in a patient of Turkish origin. In this respect, the present study is the first of its kind.

Hb Pusan is a type of a hemoglobin variant caused by the substitution of histidine, which is found in the 146^th^ amino acid residue of the beta globulin chain, for asparagine amino acid (p.His147Asn, HBB: c.439C\>A)^[@r2]^. The genomic DNA of the sample was isolated according to the manufacturer's protocols. For the Sanger sequencing of HBB gene, the Polymerase chain reaction (PCR), purification (ExoSAP-IT®, Affymetrix) and cycle sequencing PCR (BigDye® Terminator v3.1, Thermo Scientific) reactions were carried out. Products were purified (ZR DNA Sequencing Clean-up Kit TM, Zymo Research) and run by capillary electrophoresis (3500 Genetic Analyzer, Thermo Scientific). The DNA sequences obtained were analysed in the Sequencing Analysis Program and compared with the reference sequences. DNA sequencing with this method is used to detect genetic mutation of hemoglobin variants that cannot be detected by the methods such as HPLC and Cation exchange high performance liquid chromatography^[@r6],[@r7]^. Hb Pusan had close retention times in both boronate affinity HPLC method (RT:1.67 min.) used at Trinity Biotech Primus Ultra 2 hemoglobin variant analyzer and in cation exchange HPLC method (RT:1.68 min.) used at Bio-Rad Variant Turbo II hemoglobin variant analyzer. Both the boronate affinity HPLC method and the cation exchange HPLC method, provide high precision and accuracy for hemoglobin variant analysis. Furthermore they provide high accuracy measurements in thalassemia cases where HbA2 level is very important^[@r8]^. Genetic mutations that have been encountered in the same region as Hb Pusan, and that have previously been identified by the DNA chain analysis, are as follows: Hemoglobin Hiroshima (CAC\>GAC, β146 histidine → aspartic acid), Hemoglobin Bologna (CAC\>TAC, β146 histidine → Tyrosine, HBB: c.439 C\>T), Hemoglobin York (CAC\>CCC, β146 histidine → Proline, HBB: c.440 A\>C), Hemoglobin Cochin-Port Royal (CAC\>CGC β146 histidine → Arginine, HBB: c.440 A\>G), Hemoglobin Cowntown (CAC\>CTC, β146 histidine → Leucine, HBB: c.440 A\>T), Hemoglobin Kadaria I (CAC\>CAA, β146 histidine → Glycine, HBB: c.441 C\>A), and Hemoglobin Kadaria II (CAC\>CAG, β146 histidine → Glycine HBB: c.441 C\>G)^[@r9]-[@r15]^. Furthermore, all the variants of the position 146 display a mild increased oxygen affinity leading to some degree of erythrocytosis^[@r9]-[@r15]^ and apparently this seems to be the case of the carrier of Hb Pusan since the measured Hb value and RBC count are above the normal (17g/dL (reference range: 13.2-16.6 g/dL) and 5.95x10^[@r12]^/L (reference range: 3.8-5.1x10^[@r12]^/L)). Additionally, measured P50 value was low (20 mmHg) than normal control (26.5 mmHg, reference range 26±1.3 mmHg) due to mild oxygen affinity.

The clinical features and genetic mutations of many hemoglobin variants have not yet been clarified. As discussed above, there are too many hemoglobin variant types that appear even in the same gene region. Different clinical and hematological features can be seen in different hemoglobin variant types while different clinical and hematological features can also be seen in a single hemoglobin variant. Therefore, different clinical and hematological features of the hemoglobin variant, detected in the present study, can be revealed in future studies. We believe that our case study will enlighten the upcoming regional or racial studies.

Limitations {#s4}
===========

Although the present case report was well constructed, there were some limitations. Firstly, due to the lack of data on Hb Pusan case, different hematological conditions and physical examination findings in the same case could not be discussed. Secondly, family investigations which belong to this case could not be carried out because other family members did not allow testing.
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